Literature DB >> 30743264

Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.

Brandon A Mahal1, Santino Butler1, Idalid Franco1, Daniel E Spratt2, Timothy R Rebbeck1, Anthony V D'Amico1, Paul L Nguyen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30743264      PMCID： PMC6439610          DOI： 10.1001/jama.2018.19941

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.

Authors:  Bo Lennernäs; Khairul Majumder; Jan-Erik Damber; Per Albertsson; Erik Holmberg; Yvonne Brandberg; Ulf Isacsson; Gunilla Ljung; Ole Damm; Sten Nilsson
Journal:  Acta Oncol       Date:  2014-11-02       Impact factor: 4.089

2.  Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

Authors:  Matthew R Cooperberg; Peter R Carroll
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

3.  NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.

Authors:  Peter H Carroll; James L Mohler
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

4.  Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

Authors:  Stacy Loeb; Nataliya Byrne; Danil V Makarov; Herbert Lepor; Dawn Walter
Journal:  JAMA       Date:  2018-06-05       Impact factor: 56.272

5.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Authors:  Laurence Klotz; Danny Vesprini; Perakaa Sethukavalan; Vibhuti Jethava; Liying Zhang; Suneil Jain; Toshihiro Yamamoto; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544
  5 in total
  66 in total

1. 

Authors:  Roland Grad; Guylène Thériault; Harminder Singh; James A Dickinson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2019-08       Impact factor: 3.275

2.  Age to stop? Appropriate screening in older patients.

Authors:  Roland Grad; Guylène Thériault; Harminder Singh; James A Dickinson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2019-08       Impact factor: 3.275

3.  Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States.

Authors:  Bashir Al Hussein Al Awamlh; Karla V Ballman; Xiaoyue Ma; Jim C Hu; Jonathan E Shoag
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-07-13       Impact factor: 5.554

4.  Cancer Progress and Priorities: Prostate Cancer.

Authors:  Kevin H Kensler; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02       Impact factor: 4.254

5.  Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.

Authors:  Jane M Lange; Aaron A Laviana; David F Penson; Daniel W Lin; Anna Bill-Axelson; Sigrid V Carlsson; Lisa F Newcomb; Bruce J Trock; H Ballentine Carter; Peter R Carroll; Mathew R Cooperberg; Janet E Cowan; Laurence H Klotz; Ruth B Etzioni
Journal:  Cancer       Date:  2019-10-22       Impact factor: 6.860

6.  Active surveillance before radiotherapy: Outcome and predictive factors for multiple biopsies before treatment.

Authors:  Alexandre Alcaidinho; Guila Delouya; Jean-Paul Bahary; Fred Saad; Daniel Taussky
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

7.  Trends in treatments for prostate cancer in the United States, 2010-2015.

Authors:  Jianwei Wang; Harry Hua-Xiang Xia; Yuanyuan Zhang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2021-05-20       Impact factor: 6.166

8.  Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.

Authors:  Rishi Deka; P Travis Courtney; J Kellogg Parsons; Tyler J Nelson; Vinit Nalawade; Elaine Luterstein; Daniel R Cherry; Daniel R Simpson; Arno J Mundt; James D Murphy; Anthony V D'Amico; Christopher J Kane; Maria Elena Martinez; Brent S Rose
Journal:  JAMA       Date:  2020-11-03       Impact factor: 56.272

9.  Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience.

Authors:  Sigrid Carlsson; Nicole Benfante; Ricardo Alvim; Daniel D Sjoberg; Andrew Vickers; Victor E Reuter; Samson W Fine; Hebert Alberto Vargas; Michal Wiseman; Maha Mamoor; Behfar Ehdaie; Vincent Laudone; Peter Scardino; James Eastham; Karim Touijer
Journal:  J Urol       Date:  2019-12-23       Impact factor: 7.450

10.  Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.

Authors:  Robert T Dess; Yilun Sun; William C Jackson; Neil K Jairath; Amar U Kishan; David G Wallington; Brandon A Mahal; Bradley J Stish; Zachery S Zumsteg; Robert B Den; William A Hall; Laila A Gharzai; Elizabeth M Jaworski; Zachary R Reichert; Todd M Morgan; Rohit Mehra; Edward M Schaeffer; Oliver Sartor; Paul L Nguyen; William Robert Lee; Seth A Rosenthal; Jeff M Michalski; Matthew J Schipper; James J Dignam; Thomas M Pisansky; Anthony L Zietman; Howard M Sandler; Jason A Efstathiou; Felix Y Feng; William U Shipley; Daniel E Spratt
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.